Global Automated Breast Ultrasound Systems (ABUS) Market: Trends, Share, Size, Growth, Opportunity and Forecast until 2027

 

High-frequency sound waves are used in ultrasound to examine inside organs and structures. Radiation exposure is not involved in the method. A transducer that scans the entire breast is used in automated breast ultrasound to produce three-dimensional (3D) ultrasound images for cancer screening.

The SonoCiné Automated Breast Ultrasound Systems (ABUS) Market can repeatedly scan the entire breast with the consistency and accuracy required for the timely diagnosis of cancer.

Due to the Automated Breast Ultrasound Systems (ABUS) Market ultrasonography system's significantly higher accuracy in invasive breast cancer diagnosis and faster recall features, particularly when combined with full-field digital screening mammography (FFDSM), significant advancement has been observed.

In the first half of 2020, there was a minor decline in demand, which was due to the implementation of strict lockdowns during the COVID-19 pandemic. The pandemic forced doctors to only perform breast ultrasonography operations on urgent and life-threatening patients.

To stop the virus's cycle of transmission, measures were taken. The demand was constrained by the skilled experts being devoted to treating COVID patients. However, a robust recovery is anticipated given the worldwide increase in breast cancer occurrences.

Major manufacturing firms are being encouraged to develop cutting-edge, accurate, and Automated Breast Ultrasound Systems (ABUS) Market by the growing need for accurate diagnosis of breast lesions, particularly in the early stages of cancer, and the lack of radiologists with the necessary skills to use the traditional ultrasound system.

The use of high frequency sound waves to map the entire breast and produce a 3D monochrome image of the tissues and breast structure has increased demand in the market. Increased inclination for sedentary lifestyles and obesity are further factors contributing to the rising incidence of breast cancer.